ASH News Daily 2017 - Issue 3 - C-7
ancer
Emory
sity
Takeda
Oncology
Park
er
ute
Product
Theater 3
2768
NanoString
Tech
BloodCenter
of Wisconsin
Flowmetric
PromoCell
GmbH
Rare
Disease
Therapeutics
®
Ossium
Health,
Inc.
BPL
Alnylam
Pharmaceuticals
StemExpress
2655 2754
Caprico
Biotechnologies,
Inc.
Shire
Synthego
2653 2752
Medscape
Hematology/
Oncology
Portola
Macopharma Pharmaceuticals
Get Smart
Education
DAVA
Oncology
Beckman
Firma
Clinical Coulter Life
Research Sciences
AROG
Pharmaceuticals
and Mentrik
Biotech
John Theurer
Cancer Center
Hackensack
University
Medical Hospital
NEJM
Group
Aegis
Sciences
rn
Conversant
Bio
Pfizer
(Rare
Disease)
INC
Research
Mayo
Medical
Labs
WALKWAY
las
ma
WALKWAY
gy
Mayo
Clinic
Referring
Physician
Office
inSeption
bluebird bio
Bio-Rad
Labs
Predicine Inc.
Hemx
Health
Precision
Oncology
Foundation
Medicine, Inc
3149
Veristat
Northside
Hospital
Cancer Institute
MediCom
Oncology
CONNECTOR
University of
Chicago
Comprehensive
Cancer Center
CONNECTOR
er
cs
Machaon
Diagnostics
Oncology
Group/Div
of UBM
Medica
2651 2750
Biocytogen
HemOnc Today
and Healio.com
By Slack Inc
Head
shot
Alley
Karius, Inc.
Charter
Medical
Ltd.
Isoplexis
Omeros
Corp
Product
Theater 4
Covance
Inc
2657 2756
te
y
nsive
nter
es
eDx
Page C-7
Exhibitor List and Floor Plan
ENERAL SESSION
ACCESS VIA
CONNECTOR
ey's
mia
ation
ASH News Daily
Monday, December 11, 2017
Verastem
AbbVie
Stemline
Therapeutics
Exhibit Hours
Biosafe
ArcherDX
USA Inc
Today * 10:00 a.m. - 2:00 p.m.
Alexion
Pharmaceuticals
Pfizer Oncology
ApoPharma,
Inc
Miltenyi
Biotec,
GmBH
Axiom Real-Time
Metrics Inc
Kite
Pharma,
Inc
Apobiologix
Bristol-Myers Squibb
TESARO
Sunesis
Pharmaceuticals
3323
QIAGEN
Bioverativ
Wiley
H3
Biomedicine
Correspondances
en Oncohematologie
ASH
Cafe
Pharmacyclics, Inc
Genentech
CTI
BioPharma
Corp
Stemline
Therapeutics
QuintilesIMS
AstraZeneca
Rigel
Pharmaceuticals
Jazz
Pharmaceuticals
Inc
Jazz
Pharmaceuticals
Inc.
2808
HematoLogics,
Inc.
2705
Biolegend uniQure,
Inc
The
Guider
Group
Karyopharm
Therapeutics
Inc
Prometic Life
Sciences Inc
Agios
Pharmaceuticals
Takeda
Oncology
2806
Intellicyt
Corp
Entrance
Entrance
Correspondances en
Onco-hematologie ....................................... 2207
Covance, Inc. ................................................... 2661
CROMSOURCE .............................................. 2752
CTI BioPharma Corp. .....................................2115
D-E-F
Daiichi Sankyo .................................................. 125
Daiichi Sankyo .................................................. 533
Dana-Farber Cancer Institute ....................... 1642
Dana-Farber/Boston Children's
Cancer and Blood Disorders Center ......... 1644
DAVA Oncology ............................................. 2749
Diamond Blackfan Anemia Canada ............ 2052
Diamond Blackfan Anemia Foundation ..... 2054
DKMS............................................................... 1661
Dova Pharmaceuticals ................................... 1604
DRG International, Inc. ................................... 419
Drug Development Institute at
The Ohio State University
Comprehensive Cancer Center ................. 2051
Dyskeratosis Congenita Outreach, Inc........ 1949
EBSCO Health................................................... 605
Elsevier .............................................................. 303
Elsevier .............................................................. 402
Emmaus Medical, Inc. ..................................... 333
ERYtech Pharma ............................................. 2563
European Hematology Association ............. 1843
Evolve Med Tech ............................................ 2660
EZLife Bio .......................................................... 514
Fanconi Anemia Research Fund, Inc. .......... 1853
Ferrata Storti Foundation Haematologica Journal ............................... 1756
Firma Clinical Research................................. 2651
Flowmetric, Inc. .............................................. 2562
Food and Drug Administration
(FDA) Recruiting ......................................... 1560
Foundation for Sickle Cell
Disease Research ......................................... 1849
Foundation for the Accreditation
of Cellular Therapy (FACT) ....................... 1955
Foundation for Women & Girls
with Blood Disorders .................................. 1751
Foundation Medicine, Inc. ............................ 3149
G-H-I
GBT - Grupo Biotoscana.................................. 545
GE Healthcare ................................................. 3243
Genentech ........................................................ 2213
Genohm, Inc. ......................................................511
Genoptix Medical Laboratory ........................ 502
Get Smart Education ...................................... 2149
Gilead Sciences, Inc. ....................................... 1317
GlaxoSmithKline (GSK) .................................. 722
Global Blood Therapeutics ............................. 742
H3 Biomedicine, Inc. ...................................... 2107
Harborside Press, LLC .................................... 610
Haymarket Oncology ........................................ 47
Health Volunteers Overseas ......................... 1760
HealthWell Foundation ................................. 1851
Helsinn............................................................... 133
HEMA Biologics ............................................. 1203
HematoLogics, Inc. ........................................ 2806
Hematology News ........................................... 506
Hematology Specialist Association ............. 1945
Hemex Health ................................................. 3150
HemOnc Today and Healio.com
By Slack Incorporated................................. 2145
Hemostasis and Thrombosis
Research Society, Inc. (HTRS) .................... 1749
Histiocytosis Association/
Histiocyte Society ........................................ 1651
Hospital Information Services...................... 1854
Hypoxygen........................................................ 509
Imedex ............................................................... 403
Impact Biomedicines, Inc. ............................... 544
INC Research/inVentiv Health .................... 2133
Incyte Corporation ........................................... 733
Indo-American Cancer
Association (IACA) ..................................... 1744
infoScript, Powered by ecoFiles ................... 1602
inSeption Group ............................................. 3053
Intellicyt Corp. ................................................ 2700
Intellisphere, LLC ............................................. 913
International Myeloma Foundation ............ 1213
International Myeloma Society .................... 1850
International Society on
Thrombosis and Haemostasis ................... 1743
Intrinsic LifeSciences ......................................... 35
Invivoscribe Technologies, Inc. ...................... 633
»» EXHIBITOR LIST Page C-8
Table of Contents for the Digital Edition of ASH News Daily 2017 - Issue 3
ASH News Daily 2017 - Issue 3 - A-1
ASH News Daily 2017 - Issue 3 - A-2
ASH News Daily 2017 - Issue 3 - A-3
ASH News Daily 2017 - Issue 3 - A-4
ASH News Daily 2017 - Issue 3 - A-5
ASH News Daily 2017 - Issue 3 - A-6
ASH News Daily 2017 - Issue 3 - A-7
ASH News Daily 2017 - Issue 3 - A-8
ASH News Daily 2017 - Issue 3 - A-9
ASH News Daily 2017 - Issue 3 - A-10
ASH News Daily 2017 - Issue 3 - A-11
ASH News Daily 2017 - Issue 3 - A-12
ASH News Daily 2017 - Issue 3 - A-13
ASH News Daily 2017 - Issue 3 - A-14
ASH News Daily 2017 - Issue 3 - A-15
ASH News Daily 2017 - Issue 3 - A-16
ASH News Daily 2017 - Issue 3 - A-17
ASH News Daily 2017 - Issue 3 - A-18
ASH News Daily 2017 - Issue 3 - A-19
ASH News Daily 2017 - Issue 3 - A-20
ASH News Daily 2017 - Issue 3 - A-21
ASH News Daily 2017 - Issue 3 - A-22
ASH News Daily 2017 - Issue 3 - A-23
ASH News Daily 2017 - Issue 3 - A-24
ASH News Daily 2017 - Issue 3 - A-25
ASH News Daily 2017 - Issue 3 - A-26
ASH News Daily 2017 - Issue 3 - A-27
ASH News Daily 2017 - Issue 3 - A-28
ASH News Daily 2017 - Issue 3 - B-1
ASH News Daily 2017 - Issue 3 - B-2
ASH News Daily 2017 - Issue 3 - B-3
ASH News Daily 2017 - Issue 3 - B-4
ASH News Daily 2017 - Issue 3 - B-5
ASH News Daily 2017 - Issue 3 - B-6
ASH News Daily 2017 - Issue 3 - B-7
ASH News Daily 2017 - Issue 3 - B-8
ASH News Daily 2017 - Issue 3 - B-9
ASH News Daily 2017 - Issue 3 - B-10
ASH News Daily 2017 - Issue 3 - B-11
ASH News Daily 2017 - Issue 3 - B-12
ASH News Daily 2017 - Issue 3 - B-13
ASH News Daily 2017 - Issue 3 - B-14
ASH News Daily 2017 - Issue 3 - B-15
ASH News Daily 2017 - Issue 3 - B-16
ASH News Daily 2017 - Issue 3 - B-17
ASH News Daily 2017 - Issue 3 - B-18
ASH News Daily 2017 - Issue 3 - B-19
ASH News Daily 2017 - Issue 3 - B-20
ASH News Daily 2017 - Issue 3 - B-21
ASH News Daily 2017 - Issue 3 - B-22
ASH News Daily 2017 - Issue 3 - B-23
ASH News Daily 2017 - Issue 3 - B-24
ASH News Daily 2017 - Issue 3 - B-25
ASH News Daily 2017 - Issue 3 - B-26
ASH News Daily 2017 - Issue 3 - B-27
ASH News Daily 2017 - Issue 3 - B-30
ASH News Daily 2017 - Issue 3 - B-31
ASH News Daily 2017 - Issue 3 - B-32
ASH News Daily 2017 - Issue 3 - B-33
ASH News Daily 2017 - Issue 3 - B-34
ASH News Daily 2017 - Issue 3 - B-35
ASH News Daily 2017 - Issue 3 - B-36
ASH News Daily 2017 - Issue 3 - B-37
ASH News Daily 2017 - Issue 3 - B-38
ASH News Daily 2017 - Issue 3 - B-39
ASH News Daily 2017 - Issue 3 - B-40
ASH News Daily 2017 - Issue 3 - B-41
ASH News Daily 2017 - Issue 3 - B-42
ASH News Daily 2017 - Issue 3 - B-43
ASH News Daily 2017 - Issue 3 - B-44
ASH News Daily 2017 - Issue 3 - B-45
ASH News Daily 2017 - Issue 3 - B-46
ASH News Daily 2017 - Issue 3 - B-47
ASH News Daily 2017 - Issue 3 - B-48
ASH News Daily 2017 - Issue 3 - B-49
ASH News Daily 2017 - Issue 3 - B-50
ASH News Daily 2017 - Issue 3 - B-51
ASH News Daily 2017 - Issue 3 - B-52
ASH News Daily 2017 - Issue 3 - B-53
ASH News Daily 2017 - Issue 3 - B-54
ASH News Daily 2017 - Issue 3 - B-55
ASH News Daily 2017 - Issue 3 - B-56
ASH News Daily 2017 - Issue 3 - C-1
ASH News Daily 2017 - Issue 3 - C-2
ASH News Daily 2017 - Issue 3 - C-3
ASH News Daily 2017 - Issue 3 - C-4
ASH News Daily 2017 - Issue 3 - C-5
ASH News Daily 2017 - Issue 3 - C-6
ASH News Daily 2017 - Issue 3 - C-7
ASH News Daily 2017 - Issue 3 - C-8
ASH News Daily 2017 - Issue 3 - C-9
ASH News Daily 2017 - Issue 3 - C-10
ASH News Daily 2017 - Issue 3 - C-11
ASH News Daily 2017 - Issue 3 - C-12
ASH News Daily 2017 - Issue 3 - C-13
ASH News Daily 2017 - Issue 3 - C-14
ASH News Daily 2017 - Issue 3 - C-15
ASH News Daily 2017 - Issue 3 - C-16
ASH News Daily 2017 - Issue 3 - C-17
ASH News Daily 2017 - Issue 3 - C-18
ASH News Daily 2017 - Issue 3 - C-19
ASH News Daily 2017 - Issue 3 - C-20
ASH News Daily 2017 - Issue 3 - C-21
ASH News Daily 2017 - Issue 3 - C-22
ASH News Daily 2017 - Issue 3 - C-23
ASH News Daily 2017 - Issue 3 - C-24
ASH News Daily 2017 - Issue 3 - C-25
ASH News Daily 2017 - Issue 3 - C-26
ASH News Daily 2017 - Issue 3 - C-27
ASH News Daily 2017 - Issue 3 - C-28
ASH News Daily 2017 - Issue 3 - C-29
ASH News Daily 2017 - Issue 3 - C-30
ASH News Daily 2017 - Issue 3 - C-31
ASH News Daily 2017 - Issue 3 - C-32
https://www.nxtbookmedia.com